PABLO J CAGNONI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PABLO J CAGNONI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PABLO J CAGNONI. PABLO J CAGNONI is a in ALLOS THERAPEUTICS INC ($ALTH) and a VP of Clinical Affairs in ALLOS THERAPEUTICS INC ($ALTH) and a Director in CRISPR Therapeutics AG ($CRSP) and a CEO and President in Rubius Therapeutics, Inc. ($RUBY) and an Chief Executive Officer in Rubius Therapeutics, Inc. ($RUBY) and a Director in Fusion Pharmaceuticals Inc. ($FUSN).
Address: 371 BIRCH STREET DENVER 80220 CO
Companies in which PABLO J CAGNONI is an Insider
ALLOS THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PABLO J CAGNONI:
Holdings: 0 shares
Latest Transaction: Aug 13 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PABLO J CAGNONI: Director
Holdings: 7,500 shares
Current Value: $118,125
Latest Transaction: Nov 21 2019
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Fusion Pharmaceuticals Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PABLO J CAGNONI: Director
Holdings: 0 shares
Latest Transaction: Jun 30 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rubius Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PABLO J CAGNONI: CEO and President, Chief Executive Officer
Holdings: 21,000 shares
Latest Transaction: Feb 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PABLO J CAGNONI
Sentiment: All, ALTH, CRSP, FUSN, RUBY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2021 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | CEO and President | Option Exercise | A | 0.00 | 85,000 | 0 | 85,000 | |
| Feb 02 2021 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | CEO and President | Option Exercise | A | 11.97 | 375,000 | 4,488,750 | 375,000 | |
| Jun 30 2020 | FUSN | Fusion Pharmaceuti ... | CAGNONI PABLO J | Director | Option Exercise | A | 17.00 | 30,000 | 510,000 | 30,000 | |
| Apr 15 2020 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | CEO and President | Buy | P | 4.70 | 21,000 | 98,694 | 21,000 | 0 to 21 K |
| Feb 03 2020 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 7.80 | 500,000 | 3,900,000 | 500,000 | |
| Feb 03 2020 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 7.80 | 500,000 | 3,900,000 | 500,000 | |
| Nov 21 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | M | 5.59 | 7,500 | 41,925 | 63,833 |